AbolerIS Pharma Alternatives & Competitors
11 companies similar to AbolerIS Pharma — Immune Tolerance, Restored.
Companies similar to AbolerIS Pharma
Tr1X
Engineering cures for patients with autoimmune & inflammatory diseases.
San Diego, United States
ActiTrexx GmbH
ATreg - For a life without Transplant Rejection
Mainz, Germany
Apitope
Develops drugs for treatments of allergic diseases
Diepenbeek, Belgium
Q32 Bio Inc.
Revolutionizing the future of targeted immune therapeutics
Waltham, United States
Track all AbolerIS Pharma competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Alpine Immune Sciences, Inc.
Leading the Next Evolution of Immunotherapies
Seattle, United States
ISAR Bioscience GmbH
Wir bauen der Gesundheit eine Brücke - ISAR Bioscience verbindet akademischen Anspruch u...
Planegg, Germany
Allakos Inc
Antibody-based therapeutics to treat various allergies and diseases
Redwood City, United Stat...
Gracell Biotechnologies
A Member of the AstraZeneca Group
Shanghai, China
Dianthus Therapeutics, Inc.
Building a leading biotech company focused in severe autoimmune diseases.
United States
SQZ Biotechnologies
Unlocking the full potential of cell therapies for patients around the world
Watertown, United States
About AbolerIS Pharma
AbolerIS Pharma, headquartered in Belgium, is at the forefront of developing innovative therapeutic approaches aimed at regulating the immune system, with a particular focus on inducing immune tolerance. Founded in 2019 by a team with deep expertise in regulatory T cells and tolerance mechanisms, the company is positio...
Development of innovative immunomodulators, Immune system reset therapies, Advanced antibody therapy targeting CD45RC
Patients with autoimmune diseases, Individuals undergoing organ transplantation, Healthcare providers treating autoimmune conditions
Immune Tolerance, Regulatory T Cells, Immune System Regulation, Translational Expertise, Therapeutic Approaches, Inflammatory Diseases, Autoimmune Diseases, Degenerative Diseases, Novel Drugs Development, Unmet Medical Need, Immune Response Preservation
B2B, B2D
Licensing, Product Sales, Performance Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches AbolerIS Pharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at AbolerIS Pharma on 31 Mar 2026. The 11 companies listed here were last checked between 11 Sep 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
